A 30-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy in Dyslipidemic Subjects With Stage 3 Chronic Kidney Disease.
Phase of Trial: Phase III
Latest Information Update: 02 Oct 2012
At a glance
- Drugs Choline fenofibrate; Rosuvastatin
- Indications Dyslipidaemias
- Focus Registrational; Therapeutic Use
- 04 Oct 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 09 Jun 2011 Actual initiation date (Jun 2008) added as reported by ClinicalTrials.gov.
- 09 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.